# Praziquantel

Praziquantel, sold under the brandname Biltricide among others, is a medication used to treat a number of types of parasitic worm infections in mammals, birds, amphibians, reptiles, and fish. In humans specifically, it is used to treat schistosomiasis, clonorchiasis, opisthorchiasis, tapeworm infections, cysticercosis, echinococcosis, paragonimiasis, fasciolopsiasis, and fasciolosis. It should not be used for worm infections of the eye. It is taken by mouth.
Side effects in humans may include poor coordination, abdominal pain, vomiting, headache, and allergic reactions. While it may be used during pregnancy, it is not recommended for use during breastfeeding. Praziquantel is in the anthelmintic class of medications. It works partly by affecting the function of the worm's sucker.
Praziquantel was approved for medical use in the United States in 1982. It is on the World Health Organization's List of Essential Medicines.

## Medical uses

Praziquantel is used to treat diseases caused by infection with several types of internal/gastrointestinal, and external parasites, including:
* Hydatid disease caused by infection of various organs with larval stages of tapeworms of the genus Echinococcus
* Cysticercosis caused by infection of the brain and/or muscles with the eggs and larvae of the pork tapeworm Taenia solium (though it has been judged less effective than albendazole in treatment of neurocysticercosis)
* Taeniasis caused by intestinal infection with Taenia saginata and Taenia solium
* Diphyllobothriasis caused by intestinal infection with Diphyllobothrium latum
* Hymenolepiasis caused by Hymenolepis nana and Hymenolepis diminuta
* Bertielliasis caused by intestinal infection with Bertiella studeri
* In dogs and cats, whose gastrointestinal tracts are infected with the tapeworms Dipylidium caninum or Taenia taeniaeformis, respectively; praziquantel is also often used in fixed combination with pyrantel embonate against the roundworms (ascarids): Toxocara cati and Toxascaris leonina. Praziquantel is also effective against Echinococcus multilocularis.
* Schistosomiasis caused by trematodes of the genus Schistosoma: As of 2005, praziquantel is the primary treatment for human schistosomiasis, for which it is usually effective in a single dose.
* Clonorchiasis brought on by the Chinese liver fluke Clonorchis sinensis
* Opisthorchiasis brought on by the liver flukes Opisthorchis viverrini and Opisthorchis felineus
* Paragonimiasis caused by infection with lung flukes, mostly of the species Paragonimus westermani
* Fasciolopsiasis caused by the giant intestinal fluke Fasciolopsis buski
* Echinostomiasis caused by infection with intestinal flukes of the genus Echinostoma
* Metagonimiasis caused by infection with intestinal flukes of the genus Metagonimus
* Heterophyiasis caused by the intestinal fluke Heterophyes heterophyes
* Gastrodiscoidiasis caused by the intestinal fluke Gastrodiscoides hominis

## Side effects

The majority of side effects develop due to the release of the contents of the parasites as they are killed and the consequent host immune reaction. The heavier the parasite burden, the heavier and more frequent the side effects normally are.
* Central nervous system (CNS): Frequently occurring side effects are dizziness, headache, and malaise. Drowsiness, somnolence, fatigue, and vertigo have also been seen. Almost all patients with cerebral cysticercosis experience CNS side effects related to the cell-death of the parasites (headache, worsening of pre-existing neurological problems, seizures, arachnoiditis, and meningism). These side effects may be life-threatening and can be reduced by coadministration of corticosteroids. All patients with cerebral cysticercosis are strongly recommended to be hospitalized during treatment.
* Gastrointestinal tract: About 90% of all patients have abdominal pain or cramps with or without nausea and vomiting. Diarrhea may develop and may be severe with colic. Sweating, fever, and sometimes bloody stools may occur together with diarrhea.
* Liver: Asymptomatic and transient increases of liver enzymes (AST and ALT) are noted frequently (up to 27%). No case of symptomatic liver damage has been seen so far.
* Sensitivity reactions: Urticaria, rash, pruritus and eosinophilia in white blood cell counts
* Other locations/body as a whole: Lower back pain, myalgia, arthralgia, fever, sweating, various cardiac arrhythmias, and hypotension

### Pregnancy

The WHO states praziquantel is safe during pregnancy (although does not recommend use during the first trimester). Animal studies have failed to reveal evidence of fetal harm. Praziquantel is effective in reducing schistosomiasis during pregnancy. Another trial found that treatment with praziquantel did not increase the rates of low birthweight, fetal death, or congenital anomalies.

## Drug interactions

The antibiotic rifampicin decreases plasma concentrations of praziquantel.
Carbamazepine and phenytoin are reported to reduce the bioavailability of praziquantel. Chloroquine also reduces its bioavailability.
The drug cimetidine heightens praziquantel bioavailability.

## Mechanism of action

The drug's mode of action is not exactly known at present, but experimental evidence indicates praziquantel increases the permeability of the membranes of schistosome cells towards calcium ions. The drug thereby induces contraction of the parasites' muscle, resulting in paralysis in the contracted state. The dying parasites are dislodged from their site of action in the host organism and may enter systemic circulation or may be destroyed by host immune reaction (phagocytosis). Additional mechanisms including focal disintegrations and disturbances of oviposition (laying of eggs) are seen in other types of sensitive parasites.
Another hypothesis regarding the mechanism of action is that it interferes with adenosine uptake in worms. This effect may have therapeutical relevance given that the schistosome, as the Taenia and the Echinococcus (other praziquantel-sensitive parasites), is unable to synthesize purines, such as adenosine, de novo.
Bayer's Animal Health Division website states, "Praziquantel is active against cestodes (tapeworms). Praziquantel is absorbed, metabolized in the liver, and excreted in the bile. Upon entering the digestive tract from the bile, cestocidal activity is exhibited. Following exposure to praziquantel, the tapeworm loses its ability to resist digestion by the mammalian host. Because of this, whole tapeworms, including the scolices (plural of "scolex"), are very rarely passed after administration of praziquantel. In many instances, only disintegrated and partially digested pieces of tapeworms will be seen in the stool. The majority of tapeworms are digested and are not found in the feces."
Praziquantel is administered as a racemate, but only the (R)-enantiomer is biologically active; the enantiomers may be separated using a resolution of an amine obtained from praziquantel.

## Pharmacokinetics

Praziquantel is well absorbed (about 80%) from the gastrointestinal tract. However, due to extensive first-pass metabolism, only a relatively small amount enters systemic circulation. Praziquantel has a serum half-life of 0.8 to 1.5 hours in adults with normal renal and liver function. Metabolites have a half-life of 4 to 5 hours. In patients with significantly impaired liver function (Child-Pugh score B and C), the serum half-life is increased to 3 to 8 hours. Praziquantel and its metabolites are mainly excreted renally; within 24 h after a single oral dose, 70 to 80% is found in urine, but less than 0.1% as the unchanged drug. Praziquantel is metabolized through the cytochrome P450 pathway via CYP3A4. Agents that induce or inhibit CYP3A4 such as phenytoin, rifampin, and azole antifungals will affect the metabolism of praziquantel.
Praziquantel has a particularly dramatic effect on patients with schistosomiasis. Studies of those treated have shown that within six months of receiving a dose of praziquantel, up to 90% of the damage done to internal organs due to schistosomiasis infection can be reversed.

## History

Praziquantel was developed in the laboratories for parasitological research of Bayer AG and Merck KGaA in Germany (Elberfeld and Darmstadt) in the mid-1970s.

## Society and culture
### Brand names

* Biltricide (Bayer) Tablets (for human use)
* Cesol (Merck) Tablets
* Cestoved (Vedco) both tablets and injectable for veterinary use
* Cysticide (Merck) Tablets
* Distocide (Shin Poong Pharm. Co., Ltd.) tablet (for human use)
* Distoside (Chandra Bhagat Pharma Pvt Ltd) tablet (for human use)
* Droncit (Bayer) for veterinary use
* Drontal (combination with pyrantel pamoate) (Bayer) for veterinary use
* D-Worm (Farnum) for veterinary use; note that D-Worm also makes roundworm medicine containing piperidine which is not effective against tapeworms.
* Fish Tapes (Thomas Labs) for aquarium use
* Interceptor Plus chewable tablets (combination with milbemycin) (Elanco) for veterinary use. Note regular Interceptor only has milbemycin and does not contain praziquantel.
* Kaicide (Taiwan)
* Milbemax (combination with milbemycin oxime) (Novartis) for veterinary use
* Popantel (Jurox)
* PraziPro (Hikari) for aquarium use
* Praz-Tastic (NFP/National Fish Pharmaceuticals) for aquarium use
* Pure Prazi (COTS Koi/Children of the Sun Koi) for aquarium use
* PraziPure (J.K.O., Inc. d/b/a Kodama Koi Farm & Kodama Koi Garden; licensed by COTS Koi) for aquarium use
* Profender (combination with emodepside) (Bayer) for veterinary use
* Tape Worm Tabs (Trade Winds) for veterinary use
* Zentozide (Berich (Thailand) Co)

### Regulatory approval

Praziquantel is on the World Health Organization's List of Essential Medicines.
Praziquantel is not licensed for use in humans in the UK, but it can be imported when necessary on a named-patient basis. It is available in the UK as a veterinary anthelmintic.
Praziquantel is approved in the US for the treatment of schistosomiasis and liver flukes, although it is effective in other infections.

## Veterinary medicine

* Salmon poisoning disease
* Diplozoon paradoxum and other Trematoda infections of many fish species
In March 2025, the Committee for Veterinary Medicinal Products of the European Medicines Agency adopted a positive opinion, recommending the granting of a marketing authorization for the veterinary medicinal product 'Prazivetin premix for medicated feeding stuff' intended for sea bream. The applicant for this veterinary medicinal product is Vethellas S.A. The main benefit of Prazivetin is its efficacy against infestations of the gills caused by the monogenean Sparicotyle chrysophrii.